Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis. [electronic resource]
Producer: 20200123Description: 217-223 p. digitalISSN:- 1536-7355
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis -- drug therapy
- Antibodies, Antineutrophil Cytoplasmic -- blood
- Biomarkers -- blood
- Enzyme-Linked Immunosorbent Assay
- Female
- Glucocorticoids -- therapeutic use
- Humans
- Immunologic Factors -- therapeutic use
- Male
- Middle Aged
- Myeloblastin -- blood
- Remission Induction
- Rituximab -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.